554341 ApS: Financial statements 2019
CVR: 37344281
Source: annual report 2019, Danish Business Authority
01/07/2018 – 30/06/2019
554341 ApS (CVR 37344281) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 0 and a net result of DKK -682 compared with DKK 38,945 the year before. Equity in the 2019 report amounted to DKK 88,263. The solvency ratio was 88.9%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK -682
- Equity
- DKK 88,263
- Total Assets
- DKK 99,248
- Employees
- 0
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of January 1, 2019, Jens Frederik Hostrup-Henriksen has joined the board of directors of 554341 ApS.
As of January 1, 2019, Morten Løw has joined the board of directors of 554341 ApS.
As of January 1, 2019, Julie Wagner Hostrup-Henriksen has joined the board of directors of 554341 ApS.
As of January 1, 2019, Jens Frederik Hostrup-Henriksen is registered as adm. dir. of 554341 ApS.
As of January 1, 2019, Gustav Muus Ølgaard has stepped down as adm. dir. of 554341 ApS.
On January 1, 2019, the company changed its name from Øjenhospitalet Danmark Pharma Aps to 416 ApS.
About 554341 ApS
554341 ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named 416 ApS and Øjenhospitalet Danmark Pharma Aps. The management consists of Anders Marcus Fredrik Poulsen. The board consists of Morten Løw (chair), Jens Frederik Hostrup-Henriksen and Julie Wagner Hostrup-Henriksen. The company is owned by GYNGER OG KARRUSELLER ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 710,371 and a net result of DKK 835,032 compared with DKK 2,062,210 the year before. Equity in the 2025 report amounted to DKK 8,347,729.